Shopping Cart 0
Cart Subtotal
USD 0

UAE Diagnostic and Medical Testing Market Current Analysis and Forecast (2017-2026)

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 7500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 10000

Details

With the rise in lifestyle diseases, shift in care models and innovative healthcare delivery methods worldwide including the focus on preventative rather than curative care, the diagnostics & medical testing industry in the UAE is well poised to grow. Clinical laboratory services are a critical component of the healthcare sphere given their impact and effectiveness to deliver reliable and high-quality healthcare to patients. Laboratory tests help determine the existence, magnitude or absence of disease and monitor the effectiveness of treatment. Clinical Laboratory services are classified into 2 broad categories: pathology testing and imaging laboratory services. As per Frost & Sullivan’s research in 2019, Abu Dhabi & Dubai collectively contributed up to 82% of the test volumes of the overall laboratory market in UAE. Both Emirates have better healthcare infrastructure in the form of hospitals, clinics and laboratory centers along with greater penetration in the private healthcare sector.

Based on the type of testing, the market is fragmented into Routine Testing, & Specialized Testing. The Routine Testing segment grabbed the major market and dominated the market. The segment generated revenue of USD 1,697.69 million in 2020.
Based on the type of players, the market is fragmented into Public institutions, Private clinics and private hospitals, & Independent laboratories. The Private clinics and private hospitals segment grabbed the major market and dominated the market. The segment generated revenue of USD 1,139. 83 million in 2020.

Based on the testing model, the market is fragmented into In-house, & Outsourced. The In-house segment grabbed the major market and dominated the market. The segment generated revenue of USD 1,889.45 million in 2020.

Based on the end user, the market is fragmented into B2B End-users, B2C End-users, Lab Management & COVID. The B2B End-users segment grabbed the major market and dominated the market. The segment generated revenue of USD 1,421.71 million in 2020.
For a better understanding of the market adoption of the UAE Diagnostics and Medical Testing, the market is analyzed based on its regional demand in the countries such as Dubai, Abu Dhabi & Rest of UAE. Abu Dhabi dominated the market and generated 59.01 million in terms of volume in 2020 owing to greater number of laboratories, increased spending in health infrastructure & government focus & favorable policies on healthcare in the country.

Some of the major players operating in the market include NRL (National Reference Laboratories), Al Borg lab, Medsol, MENA Labs, Purehealth, Unilabs, Cleveland Clinic Abu Dhabi, SRL Diagnostics UAE, Thumbay Labs, Life Diagnostics & York Lab. Several M&A’s along with partnerships have been undertaken by these players to boost their presence in different countries in the region.
In 2019, more than 6.6 million lab tests were conducted by the Dubai Health Authority’s (DHA) Pathology and Genetics Department. According to Dr. Hussain Al Samt, who is the Director of DHA’s Pathology & Genetics Department, 70% of medical decisions depend on the results of laboratory tests and thus stressed their importance. According to him it is important for laboratories to produce accurate, timely and fast results. The DHA’s strategy is to make Dubai a global leader in delivery of world class diagnostic testing in laboratory medicine. There is a tremendous growth in diagnostic tests in the entire UAE region. For example, The National Reference laboratory (NRL) is a part of the Mubadala Healthcare Provider and is focused on setting lab test quality benchmark in the UAE region. It performs over 7.5 million tests annually, out of which 98% are done in house, which was greater quality center and reduces both turnaround time and logistics related costs. Another example is the Unilabs, which is a leading Swiss diagnostic service provider, is opening a new branch in Abu Dhabi with a testing capacity of up to 80,000 daily PCR tests.

NRL, Al Borg Lab, Medsol, MENA Labs, Purehealth, Unilabs, Cleveland Clinic Abu Dhabi, SRL Diagnostics, Thumbay Labs, Life Diagnostics, Yok Labs are some of the prominent players operating in the UAE Diagnostics and Medical Testing market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report

“Amongst Testing Type, Routine Testing segment holds the major share”
Based on testing type, the UAE Diagnostics and Medical Testing market is segmented into Routine Testing and Specialized testing. Amongst type, the routine testing segment of the diagnostic and medical testing market was valued at US$ XX million in 2020 and is likely to reach US$ XX million by 2026 and is growing at a CAGR of XX% from 2022-2026. The surging chronic diseases such as cancer, heart diseases, asthma and coupled with other transmission diseases requires routine testing, thus, gaining edge over specialized testing segment.

“Amongst Testing Model, In-House segment holds the major share”

Based on Testing Model, the UAE Diagnostics and Medical Testing market is segmented into in-house and Outsourced. Amongst testing model, in-house accounted for a market valuation of US$ XX in 2020 and is expected to reach US$ XX million by the year 2026, at a CAGR of XX % over the analyzed period. In-house testing model are less expensive, convenient and confidential coupled with helps in diagnosing disease at early stage. Therefore, in-house testing model is expected to grab significant market share in the forecasted period as well.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts
• The report presents a quick review of overall industry performance at one glance
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
• The study comprehensively covers the market across different segments
• Deep dive regional level analysis of the industry

Customization Options:

UAE Diagnostics and Medical Testing market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
READ MORE

Table Of Content

Scope

1 MARKET INTRODUCTION
1.1 Market Definitions
1.2 Limitation
1.3 Stake Holders
1.4 Currency Used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1     Research Methodology for the UAE Diagnostic and Medical Testing Market
2.1.1 Main Objective of the UAE Diagnostic and Medical Testing Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 UAE DIAGNOSTIC AND MEDICAL TESTING MARKET (VOLUME & VALUE)

6 UAE DIAGNOSTIC AND MEDICAL TESTING MARKET AMID COVID-19

7 MARKET OVERVIEW
7.1 Market Drivers
7.2 Market Restraints
7.3 Market Opportunities

8 MARKET INSIGHTS, BY TYPE OF TESTING (VOLUME & VALUE)
8.1 Routine Testing
8.2 Specialized Testing

9 MARKET INSIGHTS, BY TYPE OF PLAYERS (VOLUME & VALUE)
9.1 Public institutions
9.1.1 Routine Testing
9.1.2 Specialized Testing
9.2 Private clinics and private hospitals
9.2.1 Routine Testing
9.2.2 Specialized Testing
9.3 Independent laboratories
9.3.1 Routine Testing
9.3.2 Specialized Testing

10 MARKET INSIGHTS, BY TESTING MODEL (VOLUME & VALUE)
10.1 In-house
10.2 Outsourced

11 MARKET INSIGHTS, BY END-USER (VOLUME & VALUE)
11.1 B2B End-users
11.2 B2C End-users
11.3 COVID
11.4 Lab Management

12 MARKET INSIGHTS BY REGION
12.1 Abu Dhabi Diagnostic and Medical Testing Market
12.1.1 Market by Type of Testing
12.1.2 Market by Type of Players
12.1.3 Market by Testing Model
12.1.4 Market Insights, by End-User
12.2 Dubai Diagnostic and Medical Testing Market
12.2.1 Market by Type of Testing
12.2.2 Market by Type of Players
12.2.3 Market by Testing Model
12.2.4 Market Insights, by End-User
12.3 Rest of UAE Diagnostic and Medical Testing Market
12.3.1 Market by Type of Testing
12.3.2 Market by Type of Players
12.3.3 Market by Testing Model
12.3.4 Market Insights, by End-User

13 PRICING ANALYSIS
13.1 Average Test Price of Private Institutions
13.2 Average Test Price of Public Institutions

14 COMPETITIVE SCENARIO
14.1 Market Share Analysis, by Company, 2020 (VOLUME)
14.1.1 Market Share of Key Players in UAE Diagnostic and Medical Testing Market, 2020

15 HEALTH INSURANCE SYSTEM IN UAE

16 TOP COMPANY PROFILES
16.1 NRL (National Reference Laboratories)
16.2 Al Borg lab
16.3 Medsol
16.4 MENA Labs
16.5 Purehealth
16.6 Unilabs
16.7 Cleveland Clinic Abu Dhabi
16.8 SRL Diagnostics
16.9 Thumbay Labs
16.10 Life Diagnostics
16.11 York Lab

17 DISCLAIMER

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

With the rise in lifestyle diseases, shift in care models and innovative healthcare delivery methods worldwide including the focus on preventative rather than curative care, the diagnostics & medical testing industry in the UAE is well poised to grow. Clinical laboratory services are a critical component of the healthcare sphere given their impact and effectiveness to deliver reliable and high-quality healthcare to patients. Laboratory tests help determine the existence, magnitude or absence of disease and monitor the effectiveness of treatment. Clinical Laboratory services are classified into 2 broad categories: pathology testing and imaging laboratory services. As per Frost & Sullivan’s research in 2019, Abu Dhabi & Dubai collectively contributed up to 82% of the test volumes of the overall laboratory market in UAE. Both Emirates have better healthcare infrastructure in the form of hospitals, clinics and laboratory centers along with greater penetration in the private healthcare sector.

Based on the type of testing, the market is fragmented into Routine Testing, & Specialized Testing. The Routine Testing segment grabbed the major market and dominated the market. The segment generated revenue of USD 1,697.69 million in 2020.
Based on the type of players, the market is fragmented into Public institutions, Private clinics and private hospitals, & Independent laboratories. The Private clinics and private hospitals segment grabbed the major market and dominated the market. The segment generated revenue of USD 1,139. 83 million in 2020.

Based on the testing model, the market is fragmented into In-house, & Outsourced. The In-house segment grabbed the major market and dominated the market. The segment generated revenue of USD 1,889.45 million in 2020.

Based on the end user, the market is fragmented into B2B End-users, B2C End-users, Lab Management & COVID. The B2B End-users segment grabbed the major market and dominated the market. The segment generated revenue of USD 1,421.71 million in 2020.
For a better understanding of the market adoption of the UAE Diagnostics and Medical Testing, the market is analyzed based on its regional demand in the countries such as Dubai, Abu Dhabi & Rest of UAE. Abu Dhabi dominated the market and generated 59.01 million in terms of volume in 2020 owing to greater number of laboratories, increased spending in health infrastructure & government focus & favorable policies on healthcare in the country.

Some of the major players operating in the market include NRL (National Reference Laboratories), Al Borg lab, Medsol, MENA Labs, Purehealth, Unilabs, Cleveland Clinic Abu Dhabi, SRL Diagnostics UAE, Thumbay Labs, Life Diagnostics & York Lab. Several M&A’s along with partnerships have been undertaken by these players to boost their presence in different countries in the region.
In 2019, more than 6.6 million lab tests were conducted by the Dubai Health Authority’s (DHA) Pathology and Genetics Department. According to Dr. Hussain Al Samt, who is the Director of DHA’s Pathology & Genetics Department, 70% of medical decisions depend on the results of laboratory tests and thus stressed their importance. According to him it is important for laboratories to produce accurate, timely and fast results. The DHA’s strategy is to make Dubai a global leader in delivery of world class diagnostic testing in laboratory medicine. There is a tremendous growth in diagnostic tests in the entire UAE region. For example, The National Reference laboratory (NRL) is a part of the Mubadala Healthcare Provider and is focused on setting lab test quality benchmark in the UAE region. It performs over 7.5 million tests annually, out of which 98% are done in house, which was greater quality center and reduces both turnaround time and logistics related costs. Another example is the Unilabs, which is a leading Swiss diagnostic service provider, is opening a new branch in Abu Dhabi with a testing capacity of up to 80,000 daily PCR tests.

NRL, Al Borg Lab, Medsol, MENA Labs, Purehealth, Unilabs, Cleveland Clinic Abu Dhabi, SRL Diagnostics, Thumbay Labs, Life Diagnostics, Yok Labs are some of the prominent players operating in the UAE Diagnostics and Medical Testing market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report

“Amongst Testing Type, Routine Testing segment holds the major share”
Based on testing type, the UAE Diagnostics and Medical Testing market is segmented into Routine Testing and Specialized testing. Amongst type, the routine testing segment of the diagnostic and medical testing market was valued at US$ XX million in 2020 and is likely to reach US$ XX million by 2026 and is growing at a CAGR of XX% from 2022-2026. The surging chronic diseases such as cancer, heart diseases, asthma and coupled with other transmission diseases requires routine testing, thus, gaining edge over specialized testing segment.

“Amongst Testing Model, In-House segment holds the major share”

Based on Testing Model, the UAE Diagnostics and Medical Testing market is segmented into in-house and Outsourced. Amongst testing model, in-house accounted for a market valuation of US$ XX in 2020 and is expected to reach US$ XX million by the year 2026, at a CAGR of XX % over the analyzed period. In-house testing model are less expensive, convenient and confidential coupled with helps in diagnosing disease at early stage. Therefore, in-house testing model is expected to grab significant market share in the forecasted period as well.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts
• The report presents a quick review of overall industry performance at one glance
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
• The study comprehensively covers the market across different segments
• Deep dive regional level analysis of the industry

Customization Options:

UAE Diagnostics and Medical Testing market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
READ MORE

Scope

1 MARKET INTRODUCTION
1.1 Market Definitions
1.2 Limitation
1.3 Stake Holders
1.4 Currency Used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1     Research Methodology for the UAE Diagnostic and Medical Testing Market
2.1.1 Main Objective of the UAE Diagnostic and Medical Testing Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 UAE DIAGNOSTIC AND MEDICAL TESTING MARKET (VOLUME & VALUE)

6 UAE DIAGNOSTIC AND MEDICAL TESTING MARKET AMID COVID-19

7 MARKET OVERVIEW
7.1 Market Drivers
7.2 Market Restraints
7.3 Market Opportunities

8 MARKET INSIGHTS, BY TYPE OF TESTING (VOLUME & VALUE)
8.1 Routine Testing
8.2 Specialized Testing

9 MARKET INSIGHTS, BY TYPE OF PLAYERS (VOLUME & VALUE)
9.1 Public institutions
9.1.1 Routine Testing
9.1.2 Specialized Testing
9.2 Private clinics and private hospitals
9.2.1 Routine Testing
9.2.2 Specialized Testing
9.3 Independent laboratories
9.3.1 Routine Testing
9.3.2 Specialized Testing

10 MARKET INSIGHTS, BY TESTING MODEL (VOLUME & VALUE)
10.1 In-house
10.2 Outsourced

11 MARKET INSIGHTS, BY END-USER (VOLUME & VALUE)
11.1 B2B End-users
11.2 B2C End-users
11.3 COVID
11.4 Lab Management

12 MARKET INSIGHTS BY REGION
12.1 Abu Dhabi Diagnostic and Medical Testing Market
12.1.1 Market by Type of Testing
12.1.2 Market by Type of Players
12.1.3 Market by Testing Model
12.1.4 Market Insights, by End-User
12.2 Dubai Diagnostic and Medical Testing Market
12.2.1 Market by Type of Testing
12.2.2 Market by Type of Players
12.2.3 Market by Testing Model
12.2.4 Market Insights, by End-User
12.3 Rest of UAE Diagnostic and Medical Testing Market
12.3.1 Market by Type of Testing
12.3.2 Market by Type of Players
12.3.3 Market by Testing Model
12.3.4 Market Insights, by End-User

13 PRICING ANALYSIS
13.1 Average Test Price of Private Institutions
13.2 Average Test Price of Public Institutions

14 COMPETITIVE SCENARIO
14.1 Market Share Analysis, by Company, 2020 (VOLUME)
14.1.1 Market Share of Key Players in UAE Diagnostic and Medical Testing Market, 2020

15 HEALTH INSURANCE SYSTEM IN UAE

16 TOP COMPANY PROFILES
16.1 NRL (National Reference Laboratories)
16.2 Al Borg lab
16.3 Medsol
16.4 MENA Labs
16.5 Purehealth
16.6 Unilabs
16.7 Cleveland Clinic Abu Dhabi
16.8 SRL Diagnostics
16.9 Thumbay Labs
16.10 Life Diagnostics
16.11 York Lab

17 DISCLAIMER

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS